An increase in the cases of an unusual infection known as mucormycosis has been reported among COVID-19 recovered patients. In this regard, the government has urged pharmaceutical companies to increase the development of amphotericin-B, an antifungal medication to treat mucormycosis. Mucormycosis , also known as black fungus, is a rare but severe fungal infection caused by the mucormycetes fungus with an overall 50% mortality rate .
It affects the sinuses, brain, lungs and can be fatal in diabetics or those with severely compromised immune systems . Fever, fatigue, coughing, shortness of breath, bloody vomit, pain and redness around the eyes, and altered mental state are some of the common symptoms. Toothache, loosening of teeth , Blackish discoloration over the bridge of nose/palate, blurred or double vision with pain, skin lesion, thrombosis, Chest pain, pleural effusion, One-sided…
